Cargando…

Antitumor effect of FP3 in a breast cancer xenograft model

FP3 is a novel vascular endothelial growth factor (VEGF) blocker proposed to have antiangiogenic properties. Previous studies revealed that FP3 is a new promising agent for treating human choroidal neovascularization (CNV)-associated age-associated macular degeneration (AMD) and has an inhibitory ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	LAN, HUANRONG, ZHENG, LINGZHI, JIN, KETAO, TENG, LISONG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524272/ https://www.ncbi.nlm.nih.gov/pubmed/23251246 http://dx.doi.org/10.3892/etm.2012.773

Ejemplares similares

Individualized drug screening based on next generation sequencing and patient derived xenograft model for pancreatic cancer with bone metastasis
por: Guan, Zhonghai, et al.
Publicado: (2017)

A potential novel therapy for FGFR1-amplified pancreatic cancer with bone metastasis, screened by next-generation sequencing and a patient-derived xenograft model
por: Guan, Zhonghai, et al.
Publicado: (2019)

Assessment of a Novel VEGF Targeted Agent Using Patient-Derived Tumor Tissue Xenograft Models of Colon Carcinoma with Lymphatic and Hepatic Metastases
por: Jin, Ketao, et al.
Publicado: (2011)

Surgical management of retrorectal tumors: a retrospective study of a 9-year experience in a single institution
por: Lin, Caizhao, et al.
Publicado: (2011)

Mammotome(®) biopsy system for the resection of breast lesions: Clinical experience in two high-volume teaching hospitals
por: JIANG, YANGPING, et al.
Publicado: (2013)

Luteolin inhibits cell cycle progression and induces apoptosis of breast cancer cells through downregulation of human telomerase reverse transcriptase
por: Huang, Liming, et al.
Publicado: (2019)

Synergistic antitumor effects of cMet inhibitor in combination with anti-VEGF in colorectal cancer patient-derived xenograft models
por: Chen, Xiangheng, et al.
Publicado: (2018)

Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer
por: Lu, Jun, et al.
Publicado: (2015)

Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study
por: Yu, Xiongfei, et al.
Publicado: (2022)

Cholesterol in colorectal cancer: an essential but tumorigenic precursor?
por: He, Xing, et al.
Publicado: (2023)

Pancreatic cancer and exosomes: role in progression, diagnosis, monitoring, and treatment
por: Fang, Xingliang, et al.
Publicado: (2023)

Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment
por: He, Xing, et al.
Publicado: (2023)

Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review
por: Fang, Xingliang, et al.
Publicado: (2022)

It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer
por: Yao, Shiya, et al.
Publicado: (2023)

Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective
por: Lan, Huanrong, et al.
Publicado: (2020)

Responsive nanosystems for targeted therapy of ulcerative colitis: Current practices and future perspectives
por: Chen, Min, et al.
Publicado: (2023)

Identification for antitumor effects of tramadol in a xenograft mouse model using orthotopic breast cancer cells
por: Kim, Myoung Hwa, et al.
Publicado: (2021)

The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)
por: He, Kuifeng, et al.
Publicado: (2012)

In Silico and In Vivo Studies of a Tumor-Penetrating and Interfering Peptide with Antitumoral Effect on Xenograft Models of Breast Cancer
por: Marin, Gustavo H., et al.
Publicado: (2023)

Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway Inhibitors
por: Chen, Min, et al.
Publicado: (2023)

Yiqi Formula Enhances the Antitumor Effects of Erlotinib for Treatment of Triple-Negative Breast Cancer Xenografts
por: Liao, Ming-juan, et al.
Publicado: (2014)

Antitumor effect of Kanglaite® injection in human pancreatic cancer xenografts
por: Liu, Ying, et al.
Publicado: (2014)

UBASH3B promotes tamoxifen resistance and could be negatively regulated by ESR1
por: Jin, Ketao, et al.
Publicado: (2017)

Antitumor activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer
por: Muscella, A, et al.
Publicado: (2014)

Antitumor Activity of Intratumoral Ethanol Injection in an Orthotopic Pancreatic Cancer Cell Mouse Xenograft Model
por: Zhang, Wen-Ying, et al.
Publicado: (2018)

Antitumor Efficacy of Focused Ultrasound-MFL Nanoparticles Combination Therapy in Mouse Breast Cancer Xenografts
por: Kim, Daehyun, et al.
Publicado: (2020)

Cetuximab delivery and antitumor effects are enhanced by mild hyperthermia in a xenograft mouse model of pancreatic cancer
por: Miyamoto, Ryoichi, et al.
Publicado: (2016)

Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer
por: Huynh, Hung, et al.
Publicado: (2015)

Antitumor Effects of Delta (9)-Tetrahydrocannabinol and Cannabinol on Cholangiocarcinoma Cells and Xenograft Mouse Models
por: Leelawat, Surang, et al.
Publicado: (2022)

Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model
por: Li, Zhanrong, et al.
Publicado: (2012)

Syringocystadenoma papilliferum in the right lower abdomen: a case report and review of literature
por: Xu, Dong, et al.
Publicado: (2013)

From organ preservation to selective surgery: How immunotherapy changes colorectal surgery?
por: Yao, Shiya, et al.
Publicado: (2023)

Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes
por: Liang, Y, et al.
Publicado: (2008)

An anti-TROP2 monoclonal antibody TrMab-6 exerts antitumor activity in breast cancer mouse xenograft models
por: Tanaka, Tomohiro, et al.
Publicado: (2021)

In vivo Antitumor Activity of Hexamethylmelamine against Human Breast, Stomach and Colon Carcinoma Xenografts
por: Tanino, Hirokazu, et al.
Publicado: (1995)

Antitumor and Antiangiogenic Activities of Curcumin in Cervical Cancer Xenografts in Nude Mice
por: Yoysungnoen-Chintana, Pornphrom, et al.
Publicado: (2014)

VTIQ evaluates antitumor effects of NET-1 siRNA by UTMD in HCC xenograft models
por: Liang, Xitian, et al.
Publicado: (2018)

RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models
por: Garner, Fiona, et al.
Publicado: (2015)

Antitumor effect of toosendanin on oral squamous cell carcinoma via suppression of p-STAT3
por: Wu, Ye, et al.
Publicado: (2023)

Isospin invariant boson models for fp-shell nuclei
por: Van Isacker, P
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_rccp1mn3ptpaf210pu5ru250o5